Neo Ivy Capital Management

Position in GILD — Gilead Sciences, Inc.

CIK 1727783 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$188,120

-$613,954 QoQ

Shares Held

1,489

-74.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#1,926

of 2,266 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Neo Ivy Capital Management holds $8,085,964 across 5 Drug Manufacturers - General names. GILD ranks #5 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	144,562	$3,481,052
2	BMY	Bristol Myers Squibb Co	54,404	$3,134,758
3	ABBV	AbbVie Inc.	3,502	$881,243
4	MRK	Merck & Co., Inc.	3,119	$400,791
5	GILD	Gilead Sciences, Inc. This page	1,489	$188,120

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$188,120	1,489	-74.1%	Shares	Sole	2026-08-14
2026-03-31	$802,074	5,755	-47.4%	Shares	Sole	2026-05-15
2025-03-31	$1,226,723	10,948	-70.0%	Shares	Sole	2025-05-06
2024-12-31	$3,370,211	36,486	+2598.7%	Shares	Sole	2025-02-18
2022-06-30	$83,567	1,352	-66.8%	Shares	Sole	2022-08-16
2022-03-31	$242,437	4,078	+320.0%	Shares	Sole	2022-05-16
2021-09-30	$67,824	971	-73.2%	Shares	Sole	2021-11-16
2021-03-31	$234,348	3,626	-58.6%	Shares	Sole	2021-10-07
2020-12-31	$510,765	8,767	+802.9%	Shares	Sole	2021-02-16
2020-06-30	$74,708	971	+337.4%	Shares	Sole	2020-08-17
2020-03-31	$16,596	222	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.